Abstract
Objectives
Studies of cardiovascular function in pregnancy have shown inconsistent and, in some cases, contradictory results, particularly regarding cardiac output. While some studies report preeclampsia associated with high cardiac output, other studies suggest that preeclampsia should be further subdivided into women with high or low cardiac output. This study was conducted to examine the NT-proBNP levels in preeclampsia, intrauterine growth restriction, and hypertensive pregnancies without preeclampsia. We also examined N-terminal pro-B natriuretic peptide (NT-proBNP) levels three to four months after delivery, in preeclamptic women as well as the prediction of delivery within 10 days. In a reduced number of preeclamptic women and controls we performed echocardiograms to study their diastolic function.
Methods
We investigated the NT-proBNP levels in 213 subjects with preeclampsia only, 73 with intrauterine growth restriction, 44 with preeclampsia and intrauterine growth restriction, 211 who were hypertensive and 662 unaffected pregnancies (controls). We also performed echocardiograms on 36 preeclampsia and 19 controls before delivery and three to five months after delivery.
Results
NT-proBNP levels are higher in early onset preeclampsia than in late onset preeclampsia. Intrauterine growth restriction pregnancies showed a NT-proBNP levels similar to hypertensive and unaffected pregnancies. Compared with healthy pregnancies, women with preterm preeclampsia (<37 gestational weeks) had altered left atrial segments.
Conclusions
We observed that NT-proBNP levels are higher in early onset preeclampsia than in late onset. Moreover, diastolic dysfunction is higher in early onset than in late-onset term preeclampsia. An NT-proBNP value >136 pg/mL has a high positive predictive value for an imminent delivery within 10 days.
Acknowledgments
The authors greatly appreciate all of the collaborators from different hospitals as well as the Catedra de Inteligencia Analitica, Universidad de Oviedo, Oviedo, Spain.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Ethical approval: The study was approved by the Independent Ethics Committee of Asturias (2020.391) (10/2014).
References
1. Bamfo, JE, Kametas, NA, Nicolaides, KH, Chambers, JB. Reference ranges for tissue Doppler measures of maternal systolic and diastolic left ventricular function. Ultrasound Obstet Gynecol 2007;29:414–20. https://doi.org/10.1002/uog.3966.Search in Google Scholar
2. Ju, H, Shroff, SG, Lang, RM. Cardiovascular changes in preeclampsia. Semin Nephrol 2004;24:580–7.10.1016/j.semnephrol.2004.07.007Search in Google Scholar
3. Novelli, GP, Valensise, H, Vasapollo, B, Larciprete, G, Di Pierro, G, Altomare, F, et al.. Are gestational and essential hypertension similar? Left ventricular geometry and diastolic function. Hypertens Pregnancy 2003;22:225–37. https://doi.org/10.1081/prg-120024026.Search in Google Scholar
4. Simmons, LA, Gillin, AG, Jeremy, RW. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. Am J Physiol Heart Circ Physiol 2002;283:H1627–33. https://doi.org/10.1152/ajpheart.00966.2001.Search in Google Scholar
5. Tomsin, K, Mesens, T, Molenberghs, G, Peeters, L, Gyselaers, W. Characteristics of heart, arteries and veins in low and high cardiac output preeclampsia. Eur J Obstet Gynecol Reprod Biol 2013;169:218–22. https://doi.org/10.1016/j.ejogrb.2013.03.016.Search in Google Scholar
6. Yu, L, Zhou, Q, Peng, Q, Yang, Z. Left ventricular function of patients with pregnancy-induced hypertension evaluated using velocity vector imaging echocardiography and N-terminal pro-brain natriuretic peptide. Echocardiography 2018;35:459–66. https://doi.org/10.1111/echo.13817.Search in Google Scholar
7. Kumari, M, Kovach, T, Sheehy, B, Zabell, A, Morales, R, Moodley, SJ, et al.. Circulating NT-proBNP but not soluble corin levels were associated with preeclampsia in pregnancy-associated hypertension. Clin Biochem 2019;67:12–5. https://doi.org/10.1016/j.clinbiochem.2019.03.005.Search in Google Scholar
8. Van wijk, MJ, Kublickiene, K, Boer, K, VanBavel, E. Vascular function in preeclampsia. Cardiovasc Res 2000;47:38–48. https://doi.org/10.1016/s0008-6363(00)00087-0.Search in Google Scholar
9. Bellamy, I, Casas, JP, Hingorani, AD, Williams, DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974. https://doi.org/10.1136/bmj.39335.385301.be.Search in Google Scholar
10. Irgens, HU, Reisaeter, I, Irgens, IM, Lie, RT. Long term mortality of mothers and fathers after preeclampsia: population based cohort study. BMJ 2001;323:1213–7. https://doi.org/10.1136/bmj.323.7323.1213.Search in Google Scholar
11. Lykke, JA, Langhoff-Roos, J, Sibai, BM, Funai, EF, Triche, EW, Paidas, MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009;53:944–51. https://doi.org/10.1161/hypertensionaha.109.130765.Search in Google Scholar
12. Mongraw-Chaffin, ML, Cirillo, PM, Cohn, BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010;56:166–71. https://doi.org/10.1161/hypertensionaha.110.150078.Search in Google Scholar
13. Melchiorre, K, Sutherland, G, Sharma, R, Nanni, M, Thilaganathan, B. Mid-gestational maternal cardiovascular profile in preterm and term-preeclampsia: a prospective study. BJOG 2013;120:496–504. https://doi.org/10.1111/1471-0528.12068.Search in Google Scholar
14. Perry, H, Khalil, A, Thilaganathan, B. Preeclampsia and the cardiovascular system: an update. Trends Cardiovasc Med 2018;28:505–13. https://doi.org/10.1016/j.tcm.2018.04.009.Search in Google Scholar
15. Mueller, C, Breidthardt, T, laule-Kilian, K, Crist, M, Perruchoud, AP. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007;137:4–12. https://doi.org/10.2007/01/smw-11614.Search in Google Scholar
16. Hamad, RR, Larsson, A, Pernow, J, Bremme, K, Eriksson, J. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertens 2009;27:2257–64. https://doi.org/10.1097/HJH.0b013e3283300541.Search in Google Scholar
17. Sabria, E, Lequerica-Fernandez, P, Lafuente-Ganuza, P, Eguia-Angeles, E, Escudero, AI, Martinez-Morillo, E, et al.. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio >38 improves prediction of preeclampsia requiring delivery within 1 week: a longitudinal cohort study. Ultrasound Obstet Gynecol 2018;51:758–67. https://doi.org/10.1002/uog.19040.Search in Google Scholar
18. Kale, A, Kale, F, Yalinkaya, A, Akdeniz, N, Corruc, N. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive patients. J Perinat Med 2005;33:121–4. https://doi.org/10.1515/jpm.2005.023.Search in Google Scholar
19. Alvarez-Fernandez, I, Prieto, B, Rodriguez, V, Ruano, Y, Escudero, AI, Alvarez, FV. N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia. Clin Chim Acta 2016;463:150–7. https://doi.org/10.1016/j.cca.2016.10.033.Search in Google Scholar
20. Resnik, JL, Hong, C, Resnik, R, Kazanegra, R, Beede, J, Bhalla, V, et al.. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol 2005;193:450–4. https://doi.org/10.1016/j.ajog.2004.12.006.Search in Google Scholar
21. Borghi, C, Esposti, DD, Immordino, V, Cassani, A, Boschi, S, Bovicelli, L, et al.. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol 2000;183:140–7. https://doi.org/10.1067/mob.2000.105684.Search in Google Scholar
22. Gomez, O, Figueras, F, Fernandez, S, Bennasar, M, Martinez, JM, Puerto, B, et al.. Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation. Ultrasound Obstet Gynecol 2008;32:128–32. https://doi.org/10.1002/uog.5315.Search in Google Scholar
23. American College of Obstetricians and Gynaecologysts. Task-force on hypertension in pregnancy. Hypertension in pregnancy. Report of the American College of obstetricians and Gynaecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013;122:1122–31.Search in Google Scholar
24. Brown, MA, Magee, LA, Kenny, LC, Karumanchi, SA, McCarthy, FP, Saito, S, et al.. Hypertensive disorders of pregnancy. ISSHP classification, diagnosis and management recommendations for international practice. Hypertension 2018;72:24–43. https://doi.org/10.1161/hypertensionaha.117.10803.Search in Google Scholar
25. Sibai, M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103:981–91. https://doi.org/10.1097/01.aog.0000126245.35811.2a.Search in Google Scholar
26. von Dadelszen, P, Magee, LA, Roberts, JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143–8. https://doi.org/10.1081/prg-120021060.Search in Google Scholar
27. Vatten, LJ, Skjaerven, R. Is preeclampsia more than one disease? Br J Obstet Gynaecol 2004;111:298–302. https://doi.org/10.1111/j.1471-0528.2004.00071.x.Search in Google Scholar
28. Valensise, H, Vasapollo, B, Gagliardi, G, Novelli, GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008;52:873–80. https://doi.org/10.1161/hypertensionaha.108.117358.Search in Google Scholar
29. Lang, RM, Badano, LP, Mor-Avi, V, Afilalo, J, Armstrong, A, Ernande, L, et al.. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 2015;28:1–39. https://doi.org/10.1016/j.echo.2014.10.003.Search in Google Scholar
30. Olsen, FJ, Bertelsen, L, de Knegt, MC, Christensen, TE, Vejlstrup, N, Svendsen, JH, et al.. Multimodality cardiac imaging for the assessment of left atrial function and the association with atrial arrhythmias. Circ Cardiovasc Imaging 2016;9:e004947. https://doi.org/10.1161/circimaging.116.004947.Search in Google Scholar
31. Junus, K, Wikström, AK, Larsson, A, Olovsson, M. Placental expression of proBNP/NT-proBNP and plasma levels of NT-proBNP in early and late onset preeclampsia. Am J Hypertens 2014;27:1225–30. https://doi.org/10.1093/ajh/hpu033.Search in Google Scholar
32. Seong, WJ, Chan Kim, S, Hong, DG, Koo, TB, Park, SII. Amino-terminal pro-brain natriuretic disorders complicating pregnancy. Hypertens Pregnancy 2011;30:287–94. https://doi.org/10.3109/10641950903115046.Search in Google Scholar
33. Kumari, M, Kovach, T, Sheehy, B, Zabell, A, Morales, R, Moodley, AJ, et al.. Circulating NT-proBNP but not soluble corin levels were associated with preeclampsia in pregnancy associated hypertension. Clin Biochem 2019;67:12–5. https://doi.org/10.1016/j.clinbiochem.2019.03.005.Search in Google Scholar
34. Easterling, TR, Benedetti, TJ, Schmucker, BC, Millard, SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 1990;76:1061–9.Search in Google Scholar
35. Verlohren, S, Melchiorre, K, Khalil, A, Thilaganathan, B. Uterine artery Doppler, birth weight and timing of onset of preeclampsia: providing insights into the dual etiology of late onset preeclampsia. Ultrasound Obstet Gynecol 2014;44:293–8. https://doi.org/10.1002/uog.13310.Search in Google Scholar
36. Tay, J, Foo, L, Masini, G, Bennet, PR, McEniery, CM, Wilkinson, IB, et al.. Early and late preeclampsia are characterized by high cardiac output, but in the fetal growth restriction, cardiac output is low: insights from a prospective study. Am J Obstet Gynecol 2018;218:517e1–12. https://doi.org/10.1016/j.ajog.2018.02.007.Search in Google Scholar
37. Giannubilo, SR, Pasculli, A, Tidu, E, Biagini, A, Boscarato, V, Ciavattini, A. Relationship between maternal hemodynamics and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia and fetal growth restriction. J Perinatol 2017;37:484–7. https://doi.org/10.1038/jp.2016.264.Search in Google Scholar
38. Vaddamani, S, Keepanasseril, A, Pillai, AA, Kumar, B. Maternal cardiovascular dysfunction in women with early onset preeclampsia and late onset preeclampsia: a cross-sectional study. Pregnancy Hypertension 2017;10:247–50. https://doi.org/10.1016/j.preghy.2017.10.010.Search in Google Scholar
39. Ponikowski, P, Voors, AA, Anker, SD, Bueno, H, Cleland, JGF, Coats, AJS, et al.. Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 2016;37:2129–200. https://doi.org/10.1093/eurheartj/ehw128.Search in Google Scholar
40. Thomas, L, Marwick, TH, Popescu, BA, Donal, E, Badano, LP. Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state of the art review. J Am Coll Cardiol 2019;73:1961–77. https://doi.org/10.1016/j.jacc.2019.01.059.Search in Google Scholar
41. Yu, L, Zhou, Q, Peng, Q, Yang, Z. Left ventricular function of patients with pregnancy-induced hypertension evaluated using velocity vector imaging echocardiography and N-terminal pro-brain natriuretic peptide. Echocardiography 2018;35:459–66. https://doi.org/10.1111/echo.13817.Search in Google Scholar
42. Bakacak, M, Serin, S, Ercan, O, Köstü, B, Bakacak, Z, Kiran, H. Association of serum N-terminal probrain natriuretic peptide levels with the severity of preeclampsia. J Maternal Fetal Neonatal Medicine 2016;29:2802–6.10.3109/14767058.2015.1104663Search in Google Scholar
43. Afshani, N, Moustaqim-Barrette, A, Biccard, BM, Rodseth, RN, Dyer, RA. Utility of B-type natriuretic peptides in preeclampsia: a systematic review. Int J Obstet Anesth 2013;22:96–103. https://doi.org/10.1016/j.ijoa.2012.11.001.Search in Google Scholar
44. Saecki, P, Grabiec, M, Walentowicz-Sadlecka, M. Prenatal clinical assessment of NT-proBNP as a diagnostic tool for preeclampsia, gestational hypertension and gestational diabetes mellitus. PLoS One 2016;11:e0162957.10.1371/journal.pone.0162957Search in Google Scholar PubMed PubMed Central
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2020-1450).
© 2021 Walter de Gruyter GmbH, Berlin/Boston
